Related Experiment Videos
Epidemiology of epilepsy in children
1College of Physicains and Surgeons, Columbia University, New York, New York, USA.
Insights
Childhood convulsive disorders, including febrile seizures and epilepsy, are common. Most children with epilepsy have good outcomes, but some may need alternative treatments if seizures persist.
Area of Science:
- Neurology
- Pediatrics
- Childhood Neurologic Disorders
Background:
- Convulsive disorders are common in childhood, affecting over 4% of children.
- Febrile convulsions are the most frequent type, typically benign with geographic variations.
- Epilepsy affects approximately 1% of the population by age 20, with generally excellent prognoses.
Purpose of the Study:
- To summarize the prevalence and prognosis of childhood convulsive disorders.
- To highlight the management considerations for refractory epilepsy in children.
Main Methods:
- Literature review of childhood neurologic disorders.
- Analysis of epidemiological data on febrile convulsions and epilepsy.
- Discussion of treatment outcomes and alternative therapies for epilepsy.
Main Results:
- Convulsive disorders impact more than 4% of children.
- Febrile convulsions are common and usually benign.
- Most childhood epilepsy cases have excellent prognoses, but a small subset requires further investigation.
Conclusions:
- Childhood epilepsy generally has a favorable prognosis.
- Alternative therapies should be considered for children with epilepsy uncontrolled after two years of treatment.
- Understanding the spectrum of convulsive disorders is crucial for pediatric neurology.
Abstract:
The convulsive disorders are among the more frequently occurring neurologic disorders of childhood, affecting more than 4% of all children. The most frequently occurring disorder, febrile convulsions, shows wide geographic variation and is usually benign. Children with epilepsy (which affects about 1% of the population by age 20) generally have an excellent prognosis. The small proportion of patients whose epilepsy is not controlled after two years of treatment should be considered for alternative therapies.